Faculty by Research Area

W. Scott Campbell, MBA, PhD: Representation and computation of clinical data for use in research and clinical decision support systems development.

Chittibabu Babu Guda, PhD: Bioinformatics analysis related to cancer

Jane Meza, PhD: Statistical issues related to small area estimation; disease mapping

Nicholas Woods, PhD: Systems biology based analysis of cancer signaling pathways

Hamid Band, MD, PhD: Molecular Control of Tyrosine Kinase Signaling: Cell Biology and translation

Vimla Band, PhD: Breast cancer development

Gloria Borgstahl, PhD: Drug discovery in cancer and structural biology of DNA repair complexes

Wasim Nasser, PhD: Pathogenesis of breast cancer to brain metastasis and small cell lung cancer

Melissa Teoh, PhD: Redox signaling between cancer cells

Nicholas Woods, PhD: Systems biology based analysis of cancer signaling pathways

Hamid Band, MD, PhD: Molecular Control of Tyrosine Kinase Signaling: Cell Biology and translation

Jennifer Black, PhD: Protein kinase C signaling in intestinal cells; endometrial and colon cancer

Samuel M. Cohen, MD, PhD: Chemical carcinogenesis, toxicology and risk assessment, surgical pathology, urologic pathology

Adam R. Karpf, PhD: Ovarian cancer; epigenetics; tumor immunology

Robert Lewis, PhD: Cell growth and metabolism

Oksana Lockridge, PhD: Protein modifications resulting from exposure to organophosphorus pesticides and nerve agents

Grinu Mathew, PhD: Genetic and epigentic regulation of prostate cancer metastasis

Subu Ramanathan, PhD: Aberrant epithelial cell packing and initiation of disease

Eleanor G. Rogan, PhD: Activation of carcinogens; carcinogen-DNA adducts; and adducts with oncogenic mutations

Hamid Band, MD, PhD: Breast cancer and intracellular trafficking

Kishor Kumar Bhakat, PhD: Epigenetics; lung, breast pancreas and colon tumors

Jennifer Black, PhD: Protein kinase C signaling in intestinal cells; endometrial and colon cancer

Suyong Choi, PhD: Novel signaling mechanism,tumor survival, proliferation, metastasis, and chemoresistance in cancer

Jixin Dong, PhD: Cell proliferation; prostate and pancreatic cancer

Gargi Ghosal, PhD: Molecular basis of replication stress response in cancer and age-related disorders

Adam Karpf, PhD: Ovarian cancer; epigenetics; tumor immunology

Rob Lewis, PhD: Cell growth and metabolism

Xu Luo, PhD: Cell death and survival

Grinu Mathew, PhD: Genetic and epigenetic regulation of prostate cancer metastasis

Amar Natarajan, PhD: Development of chemical probes for protein interactions and novel treatments for cancer; chemical library screening

Rebecca Oberley-Deegan, PhD: Antioxidants; free radical signaling; effects of radiation

Michel Ouellette, PhD: Telomerase; pancreatic cancer

Aimin Peng, PhD: Cell cycle regulation and the DNA damage response

Subu Ramanathan, PhD: Aberrant epithelial cell packing and initiation of disease

Angie Rizzino, PhD: Transcription regulation; stem cells

Joyce Solheim, PhD: Immunology; cancer biology; immunotherapy development

Ying Yan, PhD: Cell signaling; radiation and chemotherapy resistance

Hamid Band, MD, PhD: Breast cancer and intracellular trafficking

Jixin Dong, PhD: Cell proliferation; prostate and pancreatic cancer

Kishor Kumar Bhakat, PhD: Epigenetics; lung, breast pancreas and colon tumors

Jennifer Black, PhD: Protein kinase C signaling in intestinal cells; endometrial and colon cancer

Kurt Fisher, MD, PhD: Evaluating novel targets for therapy in gastrointestinal tumors with K-Ras mutations, GI tract, liver, and solid organ transplant pathology

Gargi Ghosal, PhD: Molecular basis of replication stress response in cancer and age-related disorders

Adam Karpf, PhD: Ovarian cancer; epigenetics; tumor immunology

Rob Lewis, PhD: Cell growth and metabolism

Xu Luo, PhD: Cell death and survival

Grinu Mathew, PhD: Genetic and epigenetic regulation of prostate cancer metastasis

Amar Natarajan, PhD: Development of chemical probes for protein interactions and cancer treatments; chemical library screening

Rebecca Oberley-Deegan, PhD: Antioxidants; free radical signaling; effects of radiation

Michel Ouellette, PhD: Telomerase; pancreatic cancer

Aimin Peng, PhD: Cell cycle regulation and the DNA damage response

Angie Rizzino, PhD: Transcription regulation; stem cells

Joyce Solheim, PhD: Immunology; cancer biology; immunotherapy development

Ying Yan, PhD: Cell signaling; radiation and chemotherapy resistance

Jae Hyak Yoo, PhD: Uveal melanoma, ARF6 function in cancer

Hamid Band, MD, PhD: Breast cancer and intracellular trafficking

Kishore Challagundla, PhD: Role of exosomes and non-coding RNAs in developing immune therapy resistance in pediatric cancers

Martin Conda-Sheridan, PhD: Designing multifunctional biomaterial, and bioactive small molecules for cancer treatment

Jered Garrison, PhD: Targeted molecular imaging and radiotherapeutic agent design, development of cancer specific prodrugs and polymer-based drug delivery systems

So-Youn Kim, PhD: Treatment approaches to protect fertility of women who undergo chemotherapy regimens

Grinu Mathew, PhD: Genetic and epigenetic regulation of prostate cancer metastasis

DJ Murry, PharmD: Dosing strategies for Phase I clinical trials; surrogate endpoints in clinical trials;  pharmacokinetics and pharmacogenomics for individualized drug therapy

Mohd W. (Wasim) Nasser, PhD: Therapeutic targets and strategies for aggressive cancers, metastasis

Amar Natarajan, PhD: Development of chemical probes for protein interactions and novel treatments for cancer; chemical library screening

David Oupicky, PhD: Design of multifunctional nanoparticles for the treatment of metastatic cancer and inflammatory conditions

Larisa Poluektova, MD, PhD: HIV-1 Pathogenesis, therapeutics and vaccines, humanized mice for translational research, stem cell transplantation

Prakash Radhakrishnan, PhD: Glycobiology of pancreatic cancer, autocrine and paracrine cell signaling mechanisms; developing therapeutics

Angie Rizzino, PhD: Transcription regulation; stem cells

Joyce Solheim, PhD: Immunology; cancer biology; immunotherapy development

Jingjing Sun, PhDS: Development of novel effective gene/drug delivery systems for enhanced cancer therapy

Paul Trippier, PhD: Small molecule drug discovery for cancer and neurodegenerative disorders; chemical probes to dissect pathways related to disease

Ashley Wysong, MD: Skin cancer treatment and epidemiology

Chi (Kevin) Zhang, MD: Strategies for delivery of therapies to brain tumors

Jennifer Black, PhD: Protein kinase C signaling in intestinal cells; endometrial and colon cancer

Punita Dhawan, PhD: Colon cancer; cell-to-cell junctions

Kurt Fisher, MD, PhD: Therapy in gastrointestinal tumors with K-Ras mutations, GI tract, liver, and solid organ transplant pathology

Michael A. (Tony) Hollingsworth, PhD: Pancreatic cancer biochemistry, diagnostics, and treatments (including immunotherapies)

Corey Hopkins, PhD: Design, synthesis and optimization of biologically active small molecules as in vivo probes, drug discovery lead compounds and preclinical candidates

Robert Lewis, PhD: Cell growth and metabolism

Quan Ly, MD, FACS: Cadherins in metastatic cancer cell signaling and the effect of cadherin mutations on cell adhesion and cell motility

Benita McVicker, PhD: Alcoholic liver disease, liver apoptosis, liver immune regulation

Justin Mott, PhD: MicroRNAs and cancer; liver and bile duct cancer

Amar Natarajan, PhD: Development of chemical probes for protein interactions and novel treatments for cancer; chemical library screening

Prakash Radhakrishnan, PhD: Glycobiology of pancreatic cancer, autocrine and paracrine cell signaling mechanisms, pancreatic cancer therapeutics

Subu Ramanathan, PhD: Aberrant epithelial cell packing and initiation of disease

Amar Singh, PhD: Inflammation and colon cancer

Joyce Solheim, PhD: Immunology; cancer biology; immunotherapy development

Saraswathi Viswanathan, PhD: Amino acid metabolism in modulating the therapy response of pancreatic cancer.

Jennifer Black, PhD: Protein kinase C signaling in intestinal cells; endometrial and colon cancer

John Davis, PhD: Steroid synthesis and ovarian cancer

Adam R. Karpf, PhD: Ovarian cancer; epigenetics; tumor immunology

Moorthy Ponnusamy, PhD: Cancer stem cells; ovarian cancer

Hamid Band, MD, PhD: Breast cancer and intracellular trafficking

Dalia ElGamal, PhD: Lymphoid malignancies. pathogenesis of B-cell malignancies, targeted therapies for B-cell chronic lymphocytic leukemia

Kyle Hewitt, PhD: Transcriptional and epigenetic mechanisms that cause hematologic disorders

Sarah Holstein, MD, PhD: Multiple myeloma with an emphasis on the development of novel therapeutic agents

Corey Hopkins, PhD: Design, synthesis and optimization of biologically active small molecules as in vivo probes, drug discovery lead compounds and preclinical candidates

Kate Hyde, PhD: Acute myeloid leukemia

Javeed Iqbal, PhD: Lymphoma

Hamid Band, MD, PhD: Molecular Control of Tyrosine Kinase Signaling: Cell Biology and translation

Suyong Choi, PhD: Novel signaling mechanism,tumor survival, proliferation, metastasis, and chemoresistance in cancer

Leah Cook, PhD: Role of the immune system in bone metastasis and the tumor-bone microenvironment; functions of neutrophils in cancer

Dalia ElGamal, PhD: Lymphoid malignancies. pathogenesis of B-cell malignancies, targeted therapies for B-cell chronic lymphocytic leukemia

Michael A. (Tony) Hollingsworth, PhD: Pancreatic cancer biochemistry, diagnostics, and treatments (including immunotherapies)

Maneesh Jain, PhD: Tumor microenvironment; immunotherapy

Prakash Radhakrishnan, PhD: Glycobiology of pancreatic cancer, autocrine and paracrine cell signaling mechanisms, pancreatic cancer therapeutics

Rakesh K. Singh, PhD: Cancer metastasis; tumor immunology

Joyce Solheim, PhD: Immunology; cancer biology; immunotherapy development

Hamid Band, MD, PhD: Breast cancer and intracellular trafficking

Jennifer Black, PhD: Protein kinase C signaling in intestinal cells; endometrial and colon cancer

Pi-Wan Cheng, PhD: Glycobiology; intracellular organelles and trafficking

Kurt Fisher, MD, PhD: Therapy targets in gastrointestinal tumors with K-Ras mutations, GI tract, liver, and solid organ transplant pathology

Rob Lewis, PhD: Cell growth and metabolism

Grinu Mathew, PhD: Genetic and epigentic regulation of prostate cancer metastasis

Prakash Radhakrishnan, PhD: Glycobiology of pancreatic cancer, autocrine and paracrine cell signaling mechanisms; developing therapeutics

Angie Rizzino, PhD: Transcription regulation; stem cells

Joyce Solheim, PhD: Immunology; cancer biology; immunotherapy development

Hamid Band, MD, PhD: Breast cancer and intracellular trafficking

Surinder Batra, PhD: Cancer biology; functional analysis of tumor-related proteins; biomarkers as diagnostics; metastasis

Jennifer Black, PhD: Protein kinase C signaling in intestinal cells; endometrial and colon cancer

Suyong Choi, PhD: Novel signaling mechanism,tumor survival, proliferation, metastasis, and chemoresistance in cancer

Leah Cook, PhD: Role of the immune system in bone metastasis and the tumor-bone microenvironment; functions of neutrophils in cancer

Kaustubh Datta, PhD: Angiogenesis and metastasis

Kurt Fisher, MD, PhD: Evaluating novel targets for therapy in gastrointestinal tumors with K-Ras mutations, GI tract, liver, and solid organ transplant pathology

Michael A. (Tony) Hollingsworth, PhD: Pancreatic cancer biochemistry, diagnostics, and treatments (including immunotherapies)

Grinu Mathew, PhD: Genetic and epigentic regulation of prostate cancer metastasis

Aaron Mohs, PhD: Drug and imaging agent delivery; tumor metabolism

Mohd W. (Wasim) Nasser, PhD: Therapeutic targets and strategies for aggressive cancers, metastasis

Joyce Solheim, PhD: Immunology; cancer biology; immunotherapy development

Nicholas Woods, PhD: Systems biology based analysis of cancer signaling pathways

Tadayoshi Bessho, PhD: DNA interstrand crosslink repair in mammalian cells

Piero Bianco, PhD: Homologous recombination and DNA repair using E.coli as the model system, Single-molecule studies of recombinational repair enzymes

Adam Karpf, PhD: Ovarian cancer; epigenetics; tumor immunology

Grinu Mathew, PhD: Genetic and epigenetic regulation of prostate cancer metastasis

Youri Pavlov, PhD: Mutagenesis & recombination

Angie Rizzino, PhD: Transcription regulation; stem cells

Polina Shcherbakova, PhD: Mechanisms of mutagenesis mediated by translesion synthesis DNA polymerases

Tahir Tahirov, PhD: Structural biology/X-ray crystallography

Hamid Band, MD, PhD: Breast cancer and intracellular trafficking

Kishore Challagundla, PhD: Role of exosomes and non-coding RNAs in developing immune therapy resistance in pediatric cancers

Nagendra Chaturvedi, PhD: Medulloblastoma, neuroblastoma, oncogenic signaling pathways, small molecule therapeutics, stem cell biology, epigenetic regulation of pediatric cancers

Angie Rizzino, PhD: Transcription regulation; stem cells

Joyce Solheim, PhD: Immunology; cancer biology; immunotherapy development

Piero Bianco, PhD: Homologous recombination and DNA repair using E.coli, single-molecule studies of recombinational repair enzymes

Gloria Borgstahl, PhD: Drug discovery in cancer and structural biology of DNA repair complexes

Bin Duan, PhD: 3D biomimetic models of cancer microenvironment, study mechanisms, and screen potential therapeutics

Yuri Lyubchenko, Ph. D., Dr.Sc.: Protein and DNA structure/ Atomic force microscopy

Luis Marky, PhD: Biophysical studies of DNA

Amar Natarajan, PhD: Development of chemical probes for protein interactions and novel treatments for cancer; chemical library screening

Paul Sorgen, PhD: Structure and regulation of gap junctions/NMR

Tahir Tahirov, PhD: Structural biology/X-ray crystallography